Literature DB >> 21336497

Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy.

Sung Hoon Kim1, Sae Byeol Choi, Jae Gil Lee, Seung Up Kim, Mi-Suk Park, Do Young Kim, Jin Sub Choi, Kyung Sik Kim.   

Abstract

PURPOSE: There were contrary results about the effects of hepatitis B e antigen (HBeAg) positivity on the long-term survival in patients with hepatocellular carcinoma (HCC) after curative resection. PATIENTS AND METHODS: Medical records of 170 HCC patients who underwent curative liver resections were retrospectively reviewed. The 10-year survival rate and correlations among clinical, laboratory, and pathological data, especially HBeAg, were analyzed.
RESULTS: Fifty-two patients survived more than 10 years. The 10-year actual overall survival (OS) rate was 30.6%, and the actual disease-free survival (DFS) rate was 24.1%. The median OS and DFS were 76 and 35 months, respectively. In multivariate analysis, HBeAg positivity (P = 0.032; hazard ratio [HR], 3.041), presence of a satellite nodule (P = 0.007; HR, 4.166), and elevated ICG R15 (P = 0.003; HR, 4.915) had a significant negative correlation with the 10-year DFS rate. In addition, HBeAg positivity (P = 0.044; HR, 3.725) and recurrence (recur within 1 year, P < 0.001; HR, 41.296; recur after 1 year, P = 0.03; HR, 4.848) were found as independent factors which were negatively correlated to the 10-year OS.
CONCLUSIONS: The presence of HBeAg was significantly correlated to DFS and OS after curative resection for HCC. Active treatment of B viral hepatitis before and after surgery should be provided to prolong survival in patients with 5-10-cm HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336497     DOI: 10.1007/s11605-011-1452-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  40 in total

1.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.

Authors:  Nazario Portolani; Arianna Coniglio; Sara Ghidoni; Mara Giovanelli; Anna Benetti; Guido Alberto Massimo Tiberio; Stefano Maria Giulini
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.

Authors:  Sun Ha Jee; Heechoul Ohrr; Jae Woong Sull; Jonathan M Samet
Journal:  J Natl Cancer Inst       Date:  2004-12-15       Impact factor: 13.506

Review 5.  Resection and liver transplantation for hepatocellular carcinoma.

Authors:  Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

6.  Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection.

Authors:  K Shirabe; M Shimada; K Kajiyama; T Gion; Y Ikeda; H Hasegawa; K Taguchi; K Takenaka; K Sugimachi
Journal:  Cancer       Date:  1998-12-01       Impact factor: 6.860

7.  Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.

Authors:  Che-Hua Chang; Gar-Yang Chau; Wing-Yiu Lui; Shyh-Haw Tsay; Kuang-Liang King; Chew-Wun Wu
Journal:  Arch Surg       Date:  2004-03

8.  Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study.

Authors:  K J Paquet; P Koussouris; M A Mercado; J F Kalk; D Müting; W Rambach
Journal:  Br J Surg       Date:  1991-04       Impact factor: 6.939

9.  Liver transplantation for hepatocellular carcinoma: the MELD impact.

Authors:  Pratima Sharma; Vijayan Balan; Jose L Hernandez; Ann M Harper; Erick B Edwards; Hector Rodriguez-Luna; Thomas Byrne; Hugo E Vargas; David Mulligan; Jorge Rakela; Russell H Wiesner
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

10.  One thousand fifty-six hepatectomies without mortality in 8 years.

Authors:  Hiroshi Imamura; Yasuji Seyama; Norihiro Kokudo; Atsushi Maema; Yasuhiko Sugawara; Keiji Sano; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  Arch Surg       Date:  2003-11
View more
  10 in total

1.  Artificial neural network model for predicting 5-year mortality after surgery for hepatocellular carcinoma: a nationwide study.

Authors:  Hon-Yi Shi; King-Teh Lee; Jhi-Joung Wang; Ding-Ping Sun; Hao-Hsien Lee; Chong-Chi Chiu
Journal:  J Gastrointest Surg       Date:  2012-08-10       Impact factor: 3.452

2.  A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients.

Authors:  Cho Rok Lee; Jin Hong Lim; Sung Hoon Kim; Sang Hoon Ahn; Young Nyun Park; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2012-07-19       Impact factor: 3.452

3.  Predictors of recurrence in hepatitis C virus related hepatocellular carcinoma after hepatic resection: a retrospective cohort study.

Authors:  Mohamed Abdel Wahab; Ahmed Shehta; Hosam Hamed; Ayman El Nakeeb; Tarek Salah
Journal:  Eurasian J Med       Date:  2014-02

4.  Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment.

Authors:  Wei Yang; Kun Yan; S Nahum Goldberg; Muneeb Ahmed; Jung-Chieh Lee; Wei Wu; Zhong-Yi Zhang; Song Wang; Min-Hua Chen
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 5.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

6.  Long-term outcome after liver resection and clinicopathological features in patients with small hepatocellular carcinoma.

Authors:  Young Ju Hong; Sung Hoon Kim; Gi Hong Choi; Kyung Sik Kim; Jin Sub Choi
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-12-15

7.  An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy.

Authors:  Yukio Tokumitsu; Takao Tamesa; Satoshi Matsukuma; Noriaki Hashimoto; Yoshinari Maeda; Yoshihiro Tokuhisa; Kazuhiko Sakamoto; Tomio Ueno; Shoichi Hazama; Hiroyuki Ogihara; Yusuke Fujita; Yoshihiko Hamamoto; Masaaki Oka; Norio Iizuka
Journal:  Int J Oncol       Date:  2014-12-17       Impact factor: 5.650

8.  The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism.

Authors:  Xin Zheng; Natalia B Rumie Vittar; Xiaohong Gai; Maite G Fernandez-Barrena; Catherine D Moser; Chunling Hu; Luciana L Almada; Angela L McCleary-Wheeler; Sherine F Elsawa; Anne M Vrabel; Abdirashid M Shire; Andrea Comba; Snorri S Thorgeirsson; Youngsoo Kim; Qingguang Liu; Martin E Fernandez-Zapico; Lewis R Roberts
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

9.  Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.

Authors:  Sung Keun Park; Young Kul Jung; Dong Hae Chung; Keon Kuk Kim; Yeon Ho Park; Jung Nam Lee; Oh Sang Kwon; Yun Soo Kim; Duck Joo Choi; Ju Hyun Kim
Journal:  Korean J Intern Med       Date:  2013-07-01       Impact factor: 2.884

10.  The optimal follow-up period in patients with above 5-year disease-free survival after curative liver resection for hepatocellular carcinoma.

Authors:  Sang Hyun Ahn; Sung Hoon Kim; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  J Korean Surg Soc       Date:  2013-11-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.